🔗 Share this article Individuals Coming Off Anti-Obesity Injections Gain Back Pounds at a Quadrupled Rate Compared to Dieters Obesity treatment often requires ongoing approaches. A recent study indicates that people who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who halt conventional diet and exercise plans. Findings released in a leading health publication shows that while overweight people frequently drop a large proportion of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping. "Individuals purchasing such treatments need to be informed of the potential of fast weight regain when the treatment ends," stated researcher Dr. Susan Jebb. Such speed of regain means a return to original weight within about a year and a half. Weighing Therapies The research, which examined dozens of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with conventional dieting. Scientists emphasize that individuals who shed pounds through lifestyle changes alone usually experience a more gradual creep back—perhaps 0.1 kg a month—once they finish. The Reason for the Fast Rebound Experts propose the way of the jabs explains the accelerated weight return. These medications mimic a natural hormone called GLP-1, which moderates hunger. "Long-term administration of the hormone concentrations far above than normal might result in the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert. "Discontinuation of this medication means appetite is unsuppressed, making overeating much more probable." A Chronic Condition? The NHS suggest the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes. Many experts say that, given the likelihood of relapse, the treatment should be considered life-long. This perspective is supported by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," comparing it to managing diseases like diabetes. User Accounts People who have stopped the medication explain a sudden resurgence of hunger. "It was like a trigger activating and you become starving," described a patient. This difficulty is worsened if users have not adopted sustainable lifestyle or habit modifications during treatment. Significant Interest Figures indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial. Use is more common among females than males. The middle-aged age group shows the greatest usage rates. A large proportion obtain the drugs through private healthcare rather than public health services. Ultimately, researchers emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a standalone fix and maintained weight loss likely depends on ongoing lifestyle support.
Obesity treatment often requires ongoing approaches. A recent study indicates that people who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who halt conventional diet and exercise plans. Findings released in a leading health publication shows that while overweight people frequently drop a large proportion of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping. "Individuals purchasing such treatments need to be informed of the potential of fast weight regain when the treatment ends," stated researcher Dr. Susan Jebb. Such speed of regain means a return to original weight within about a year and a half. Weighing Therapies The research, which examined dozens of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with conventional dieting. Scientists emphasize that individuals who shed pounds through lifestyle changes alone usually experience a more gradual creep back—perhaps 0.1 kg a month—once they finish. The Reason for the Fast Rebound Experts propose the way of the jabs explains the accelerated weight return. These medications mimic a natural hormone called GLP-1, which moderates hunger. "Long-term administration of the hormone concentrations far above than normal might result in the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert. "Discontinuation of this medication means appetite is unsuppressed, making overeating much more probable." A Chronic Condition? The NHS suggest the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes. Many experts say that, given the likelihood of relapse, the treatment should be considered life-long. This perspective is supported by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," comparing it to managing diseases like diabetes. User Accounts People who have stopped the medication explain a sudden resurgence of hunger. "It was like a trigger activating and you become starving," described a patient. This difficulty is worsened if users have not adopted sustainable lifestyle or habit modifications during treatment. Significant Interest Figures indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial. Use is more common among females than males. The middle-aged age group shows the greatest usage rates. A large proportion obtain the drugs through private healthcare rather than public health services. Ultimately, researchers emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a standalone fix and maintained weight loss likely depends on ongoing lifestyle support.